查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439336

深部腦部刺激器 - 全球市場考量、競爭格局、市場預測 (2030)

Deep Brain Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計2023年全球深部腦部刺激（DBS）市場規模將達13.1億美元，2030年將達到23.7億美元，預計2024-2030年期間複合年增長率為10.40%。由於帕金森氏症等運動障礙的盛行率不斷增加、DBS治療適用的疾病範圍擴大、人口老化的增加以及產品開發中研發活動的增加，預計對深部腦刺激設備的需求將不斷增長。導致預測期內的市場成長。

深部腦部刺激器的市場動態

由於帕金森氏症、肌張力失調和震顫等各種運動障礙的盛行率不斷上升，DBS 設備市場的市場收入正在增加。根據國際帕金森與運動障礙協會International Parkinson and Movement Disorder Society提供的數據，預計2020年全球約有940萬人受到帕金森氏症的影響。帕金森氏症與多種臨床症狀有關，從震顫和姿勢不穩定到運動僵硬和缺乏平衡。據報導，深部腦部刺激在治療帕金森氏症方面具有有益效果，DBS 設備有針對性地刺激神經細胞，有助於緩解症狀。因此，帕金森氏症患者數量的增加將增加對DBS設備的需求，預計這將導致深部腦部刺激器市場在預測期內（2024-2030年）出現正成長。

導致 DBS 設備需求增加的另一個主要因素是全球癲癇患者數量的增加。根據世界衛生組織（WHO）提供的數據，2019年全球有近5,000萬人患有癲癇症，使其成為世界上最常見的神經系統疾病之一。癲癇的特徵是不同長度的反覆發作。據報導，深部腦部刺激對於對藥物治療無反應且不適合癲癇手術的癲癇患者有益。因此，癲癇族群的增加預計也將帶動對DBS設備的需求，進而帶動深部腦部刺激器市場的成長。

除了上述參數外，老年人口的增加、DBS設備治療適應症的擴大、高度活躍的腦深部刺激產品研發等也將在預測期內積極刺激腦深部刺激系統市場，這是主要因素。

然而，與DBS設備安裝手術相關的併發症以及市場上最終用戶對DBS系統的選擇有限可能是DBS設備市場成長的某些限制因素。

除了上述因素之外，由於作為遏制 COVID-19 傳播的必要措施而實施的封鎖，深部腦部刺激市場經歷了暫時的挫折。這段期間的主要措施之一是暫停了許多擇期手術和門診，這減少了市場對 DBS 設備的需求，並在短時間內限制了市場成長。然而，隨著世界各地多種 COVID-19 疫苗的批准和管理，深部腦部刺激器市場正處於恢復階段，導致包括醫療保健服務在內的各個領域的活動恢復。

深部腦部刺激器市場區隔分析

在深部腦部刺激設備市場的產品類型部分，預計雙通道深部腦部刺激系統在預測期內將佔據顯著的市場份額。這可以歸因於雙通道神經刺激器具有兩個獨立的 DBS 引線，從而對患者進行雙邊治療。事實證明，雙通道 DBS 系統的放置比單通道 DBS 系統更具優勢，因為它們需要更少的切口和更少的延伸隧道。因此，預計上述因素將對預測期內雙通道 DBS 設備的需求產生正面影響，並有助於預測期內深部腦部刺激設備市場的整體成長。

預計北美將主導整個深部腦部刺激器市場。

在所有地區中，北美預計將佔據 DBS 設備市場的主要市場份額。由於運動障礙和強迫症(OCD) 等適應症的高盛行率、人們對這些疾病和可能的治療方法的認識不斷提高，以及人口老齡化不斷增加，政府加大了提高認識的努力，預計北美將佔據主導市場份額有關運動障礙和治療等的研究，預計將推動北美深部腦部刺激器市場的成長。此外，高可支配收入、先進的醫療基礎設施、新產品批准和持續的產品開發也推動了該地區的市場成長。

本報告研究分析了全球深部腦部刺激器市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

目錄

第一章深部腦部刺激器市場報告簡介

第二章深部腦部刺激器市場執行摘要

  • 調查範圍
  • 市場概況
  • 競爭評估
  • 財務基準

第三章 法規與專利分析

  • 美國
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
  • 日本

第四章深部腦部刺激器市場關鍵因素分析

  • 深部腦部刺激器市場驅動因素
    • 運動障礙盛行率上升
    • 擴大 DBS 療法適用的疾病範圍
    • 老年人口增加
    • 改進 DBS 設備的產品設計與功能
  • 深部腦部刺激器市場的抑制因素與挑戰
    • DBS 手術相關的併發症
    • 最終用戶的 DBS 系統選擇有限
  • 深部腦部刺激器市場機會
    • 推出針對新興市場的產品
    • 提高產品安全性

第五章 波特五力分析深部腦部刺激器市場

第六章 COVID-19對深部腦部刺激器市場的影響分析

第七章 深部腦部刺激器市場佈局

  • 按產品類型
    • 單通道DBS設備
    • 雙通道DBS設備
  • 依電池類型
    • 可充電的
    • 不可充電
  • 按用途
    • 帕金森病
    • 癲癇
    • 強迫症
    • 肌張力失調
    • 其他
  • 按最終用戶
    • 醫院
    • 專科診所
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第八章腦深部刺激設備市場：全球公司份額分析- 3至5家主要公司

第九章深部腦部刺激器市場公司與產品概況

  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • ALEVA NEUROTHERAPEUTICS SA.
  • Beijing PINS Medical Co., Ltd.
  • Newronika S.p.A.

第10章 項目方法

  • 二次資料
  • 一次資料
  • 數據三角測量
  • 主要專家意見

第11章 KOL觀點

第12章 DelveInsight服務內容

第13章 免責聲明

第 14 章關於 DelveInsight

Product Code: DIMDCL0128

Deep Brain Stimulation Devices Market By Product Type (Single Channel And Dual Channel), By Battery Type (Rechargeable And Non-Rechargeable), By Application (Parkinson's Disease, Epilepsy, Obsessive Compulsive Disorder, Dystonia, And Others), By End User (Hospitals And Specialty Clinics), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of parkinson's disease and epilepsy.

Global Deep Brain Stimulation Devices (DBS) Market was valued at USD 1.31 billion in 2023, growing at a CAGR of 10.40% during the forecast period from 2024 to 2030 to reach USD 2.37 billion by 2030. The demand for deep brain stimulation devices is witnessing growth owing to the growing prevalence of movement disorders such as Parkinson's disease, expansion of disease indications for DBS therapy, rising geriatric population, and increasing research and development activities in product development are expected to aid in the growing demand for DBS devices leading to the growth of the DBS devices market during the forecast period.

Deep Brain Stimulation Devices Market Dynamics:

The DBS devices market is witnessing an increase in market revenue owing to the rising prevalence of various movement disorders such as Parkinson's disease, dystonia and tremors among others. According to the data provided by the International Parkinson and Movement Disorder Society, it was estimated that in 2020, approximately 9.4 million of the global population was suffering from Parkinson's disease. Parkinson's disease is associated with a variety of clinical manifestations ranging from tremors and postural instability to rigidity in movement and lack of balance. Deep brain stimulation has been reported to provide beneficial outcomes in the treatment of Parkinson's disease, wherein targeted stimulation of neurons by DBS devices help in the alleviation of symptoms. Therefore, the demand for DBS devices is set to increase due to the rising number of Parkinson's disease patients, thereby projecting positive growth for the deep brain stimulation devices market during the forecast period (2024-2030).

Another key factor leading to the increased demand for the DBS devices is the increase in the prevalent population of epilepsy patients across the globe. As per the data provided by the World Health Organization, in 2019, near about 50 million people across the world had epilepsy making it one of the most common neurological diseases in the world. Epilepsy is characterized by recurrent seizures of varying lengths. Deep brain stimulation has been reported to be beneficial for epilepsy patients who have not been benefitted from medications and do not qualify for epilepsy surgery. Therefore, the rising epileptic population is also expected to drive the demand for DBS devices, which in turn would result in the growth of the deep brain stimulation devices market.

Along with the aforementioned parameters, the rising geriatric population, expansion of indications to be treated with DBS devices and the highly active research and development area for the deep brain stimulation products are some of the other key contributing factors which will stimulate the deep brain stimulation systems market positively during the forecast period.

However, complications associated with the DBS devices placement surgery, limited options of DBS systems for end users in the market may prove to be certain restraints to the DBS devices market growth.

In addition to the previously mentioned factors, the deep brain stimulation market witnessed a period of temporary setback due to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for DBS devices in the market, thereby limiting the market growth for a short time. Nevertheless, the market for deep brain stimulation devices is on the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the DBS devices market during the forecast period.

Deep Brain Stimulation Devices Market Segment Analysis:

Deep Brain Stimulation Devices Market by Product Type (Single Channel and Dual Channel), by Battery Type (Rechargeable and Non-Rechargeable), by Application (Parkinson's Disease, Epilepsy, Obsessive Compulsive Disorder, Dystonia, and Others), by End User (Hospitals and Specialty Clinics), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the deep brain stimulation devices market, the dual channel deep brain stimulation systems are estimated to account for the prominent market share during the forecast period. This can be ascribed to the fact that dual channel neurostimulators are equipped with two separate DBS leads which enable the devices to provide bilateral therapy to patients. The placement of dual channel DBS systems require fewer incisions and less tunneling of extensions which prove to be advantageous over single-channel DBS systems. Thus, the factors mentioned above are going to influence the demand for dual channel DBS devices positively during the forecast period, thereby contributing in the overall growth of the deep brain stimulation devices market during the forecast period.

North Amercia is expected to dominate the overall Deep Brain Stimulation Devices Market:

Among all the regions, North America is expected to account for the significant market share in the DBS devices market. North America is predicted to account for the dominant market share because of the high prevalence of movement disorders and other indications such as obsessive compulsive disorder (OCD), increasing awareness regarding such diseases and their possible treatment methods, rising population of the elderly as well as rising government initiatives for creating awareness regarding movement disorders and treatment are expected to aid in the growth of the North America deep brain stimulation devices market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and advancements in product development also propelled the market growth in this region.

The North American DBS devices market is witnessing an upward trend due to the rising prevalence of obsessive compulsive disorder among other factors. As per the data provided by the Anxiety & Depression Association of America, in 2020, near about 2.2 million people were diagnosed with OCD in the United States. It has been reported in many studies that deep brain stimulation has proven to be beneficial in alleviating OCD symptoms in patients. Therefore, the increase in patient population of OCD in the United States is expected to aid in the growing demand for DBS devices, which in turn in expected to drive the growth of the United States deep brain stimulation devices market.

Besides United States, the demand for DBS devices is set to increase in other North American countries such as Canada also due to the increase in patient population of movement disorders such as Parkinson's disease. According to the data provided by a Canada-based organization-Parkinson Canada, in 2020, approximately 100,000 people were living were PD in the country. The data further stated that from the current average of 25 Canadians being diagnosed with Parkinson's disease each day, the average is expected to rise to 50 people per day by 2031. Therefore, the estimates regarding the increase in patient population of PD in Canada would lead to the increase in demand for deep brain stimulation devices, thereby providing a positive market outlook for the DBS systems market during the forecast period.

Along with the factors mentioned above, the conducive environment for product development and launches in the country further motivates the market players to enhance their presence in North America. For instance, in 2018, the US Food and Drug Administration approved DBS therapy for epilepsy thereby expanding the scope of indications, which in turn is expected to contribute to the increase in product demand thereby supporting the growth of the North America DBS devices market during the forecast period.

Deep Brain Stimulation Devices Market Key Players:

Some of the key market players operating in the DBS devices market includes Abbott, Medtronic, Boston Scientific Corporation, ALEVA NEUROTHERAPEUTICS SA., Newronika S.p.A., Beijing PINS Medical Co., Ltd. and others.

Recent Developmental Activities in Deep Brain Stimulation Devices Market:

In June 2022, Medtronic received the product approval by the US Food and Drug Administration for First-of-its-Kind SenSight(TM) Directional Lead System for DBS Therapy.

In January 2022, Boston Scientific received the product approval from the US FDA for their fourth generation Vercise Genus Deep Brain Stimulation (DBS) System used in the treatment of symptoms associated with advanced Parkinson's disease.

In September 2020, Boston Scientific received the CE mark approval from the Vercise Genus Deep Brain Stimulation (DBS) System used in the treatment of symptoms associated with advanced Parkinson's disease.

Key Takeaways from the Deep Brain Stimulation Devices Market Report Study

Market size analysis for current DBS devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the DBS devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global DBS devices market.

Various opportunities available for the other competitor in the DBS devices market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current DBS devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for DBS devices market growth in the coming future?

Target Audience who can be benefited from this Deep Brain Stimulation Devices Market Report Study

Deep Brain Stimulation Devices products providers

Research organizations and consulting companies

Deep Brain Stimulation Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in DBS devices

Various End-users who want to know more about the DBS devices market and latest technological developments in the DBS devices market.

Frequently Asked Questions for Deep Brain Stimulation Devices Market:

1. What is a Deep Brain Stimulation Device?

Deep brain stimulation (DBS) is a device that sends electrical signals to brain areas responsible for body movement. Electrodes are placed deep in the brain and are connected to a stimulator device. The device design in identical to that of a heart pacemaker.

2. What is the market for Global Deep Brain Stimulation Devices?

Global Deep Brain Stimulation Devices (DBS) Market was valued at USD 1.31 billion in 2023, growing at a CAGR of 10.40% during the forecast period from 2024 to 2030 to reach USD 2.37 billion by 2030.

3. What are the drivers for Global Deep Brain Stimulation Devices Market?

The demand for deep brain stimulation devices is witnessing growth due to the growing prevalence of movement disorders such as Parkinson's disease, expansion of disease indications for DBS therapy, rising geriatric population, and increasing research and development activities in product development are expected to aid in the growing demand for DBS devices leading to the growth of the DBS devices market in the forecast period.

4. Who are the key players operating in Global Deep Brain Stimulation Devices Market?

Some of the key market players operating in the Global DBS systems market are Abbott, Medtronic, Boston Scientific Corporation, ALEVA NEUROTHERAPEUTICS SA., Newronika S.p.A., Beijing PINS Medical Co., Ltd. and others.

5. Which region has the highest share in Deep Brain Stimulation Devices market?

Among all the regions, North America is expected to account for the significant market share in the DBS devices market. North America is predicted to account for the dominant market share because of the high prevalence of movement disorders and other indications such as obsessive compulsive disorder (OCD), increasing awareness regarding such diseases and their possible treatment methods, rising population of the elderly as well as rising government initiatives for creating awareness regarding movement disorders and treatment are expected to aid in the growth of the North America deep brain stimulation devices market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and advancements in product development also propelled the market growth in this region.

Table of Contents

1. Deep Brain Stimulation Devices Market Report Introduction

2. Deep Brain Stimulation Devices Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
    • 3.2.1 Germany
    • 3.2.2 France
    • 3.2.3 Italy
    • 3.2.4 Spain
    • 3.2.5 U.K.
  • 3.3 Japan

4. Deep Brain Stimulation Devices Market Key Factors Analysis

  • 4.1 Deep Brain Stimulation Devices Market Drivers
    • 4.1.1 Rising Prevalence of Movement Disorders
    • 4.1.2 Expansion of Disease Indications for DBS Therapy
    • 4.1.3 Rising Geriatric Population
    • 4.1.4 Improving Product Design and Features of DBS Devices
  • 4.2 Deep Brain Stimulation Devices Market Restraints and Challenges
    • 4.2.1 Complications Associated with DBS Procedures
    • 4.2.2 Limited Options of DBS Systems for End Users
  • 4.3 Deep Brain Stimulation Devices Market Opportunities
    • 4.3.1 Targeting Emerging Markets for Product Launches
    • 4.3.2 Product Improvement in Terms of Safety

5. Deep Brain Stimulation Devices Market Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Deep Brain Stimulation Devices Market

7. Deep Brain Stimulation Devices Market Layout

  • 7.1 By Product Type
    • 7.1.1 Single-Channel DBS Devices
    • 7.1.2 Dual-Channel DBS Devices
  • 7.2 By Battery Type
    • 7.2.1 Rechargeable
    • 7.2.2 Non-rechargeable
  • 7.3 By Application
    • 7.3.1 Parkinson's Disease
    • 7.3.2 Epilepsy
    • 7.3.3 Obsessive Compulsive Disorder
    • 7.3.4 Dystonia
    • 7.3.5 Others
  • 7.4 By End User
    • 7.4.1 Hospitals
    • 7.4.2 Specialty Clinics
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 North America Deep Brain Stimulation Devices Market, by Product Type
      • 7.5.1.2 North America Deep Brain Stimulation Devices Market, by Battery Type
      • 7.5.1.3 North America Deep Brain Stimulation Devices Market, by Application
      • 7.5.1.4 North America Deep Brain Stimulation Devices Market, by End User
      • 7.5.1.5 North America Deep Brain Stimulation Devices Market, by Country
      • 7.5.1.5.1 United States
      • 7.5.1.5.2 Canada
      • 7.5.1.5.3 Mexico
    • 7.5.2 Europe
      • 7.5.2.1 Europe Deep Brain Stimulation Devices Market, by Product Type
      • 7.5.2.2 Europe Deep Brain Stimulation Devices Market, by Battery Type
      • 7.5.2.3 Europe Deep Brain Stimulation Devices Market, by Application
      • 7.5.2.4 Europe Deep Brain Stimulation Devices Market, by End User
      • 7.5.2.5 Europe Deep Brain Stimulation Devices Market, by Country
      • 7.5.2.5.1 France
      • 7.5.2.5.2 Germany
      • 7.5.2.5.3 United Kingdom
      • 7.5.2.5.4 Italy
      • 7.5.2.5.5 Spain
      • 7.5.2.5.6 Russia
      • 7.5.2.5.7 Rest of Europe
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 Asia-Pacific Deep Brain Stimulation Devices Market, by Product Type
      • 7.5.3.2 Asia-Pacific Deep Brain Stimulation Devices Market, by Battery Type
      • 7.5.3.3 Asia-Pacific Deep Brain Stimulation Devices Market, by Application
      • 7.5.3.4 Asia-Pacific Deep Brain Stimulation Devices Market, by End User
      • 7.5.3.5 Asia-Pacific Deep Brain Stimulation Devices Market, by Country
      • 7.5.3.5.1 China
      • 7.5.3.5.2 Japan
      • 7.5.3.5.3 India
      • 7.5.3.5.4 Australia
      • 7.5.3.5.5 South Korea
      • 7.5.3.5.6 Rest of Asia Pacific
    • 7.5.4 Rest of the World (RoW)
      • 7.5.4.1 RoW Deep Brain Stimulation Devices Market, by Product Type
      • 7.5.4.2 RoW Deep Brain Stimulation Devices Market, by Battery Type
      • 7.5.4.3 RoW Deep Brain Stimulation Devices Market, by Application
      • 7.5.4.4 RoW Deep Brain Stimulation Devices Market, by End User
      • 7.5.4.5 RoW Deep Brain Stimulation Devices Market, by Country
      • 7.5.4.5.1 Middle East
      • 7.5.4.5.2 Africa
      • 7.5.4.5.3 South America

8. Deep Brain Stimulation Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Deep Brain Stimulation Devices Market Company and Product Profiles

  • 9.1 Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Medtronic
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 Boston Scientific Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 ALEVA NEUROTHERAPEUTICS SA.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Beijing PINS Medical Co., Ltd.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Newronika S.p.A.,
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy

10. PROJECT APPROACH

  • 10.1 Secondary Sources
  • 10.2 Primary Sources
  • 10.3 Data Triangulation
  • 10.4 Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis
  • Table 3 Dep Brain Stimulation Devices in Global (2021-2030)
  • Table 4 Deep Brain Stimulation Devices in Global by Product Type (2021-2030)
  • Table 5 Deep Brain Stimulation Devices in Global by Battery Type (2021-2030)
  • Table 6 Deep Brain Stimulation Devices in Global by Application (2021-2030)
  • Table 7 Deep Brain Stimulation Devices in Global by End User (2021-2030)
  • Table 8 Deep Brain Stimulation Devices in Global by Geography (2021-2030)
  • Table 9 Deep Brain Stimulation Devices in North America (2021-2030)
  • Table 10 Deep Brain Stimulation Devices in North America by Product Type (2021-2030)
  • Table 11 Deep Brain Stimulation Devices in North America by Battery Type (2021-2030)
  • Table 12 Deep Brain Stimulation Devices in North America by Application (2021-2030)
  • Table 13 Deep Brain Stimulation Devices in North America by End User (2021-2030)
  • Table 14 Deep Brain Stimulation Devices in North America by Country (2021-2030)
  • Table 15 Deep Brain Stimulation Devices in the US (2021-2030)
  • Table 16 Deep Brain Stimulation Devices in Canada (2021-2030)
  • Table 17 Deep Brain Stimulation Devices in Mexico (2021-2030)
  • Table 18 Deep Brain Stimulation Devices in Europe (2021-2030)
  • Table 19 Deep Brain Stimulation Devices in Europe by Product Type (2021-2030)
  • Table 20 Deep Brain Stimulation Devices in Europe by Battery Type (2021-2030)
  • Table 21 Deep Brain Stimulation Devices in Europe by Application (2021-2030)
  • Table 22 Deep Brain Stimulation Devices in Europe by End User (2021-2030)
  • Table 23 Deep Brain Stimulation Devices in Europe by Country (2021-2030)
  • Table 24 Deep Brain Stimulation Devices in France (2021-2030)
  • Table 25 Deep Brain Stimulation Devices in Germany (2021-2030)
  • Table 26 Deep Brain Stimulation Devices in the United Kingdom (2021-2030)
  • Table 27 Deep Brain Stimulation Devices in Italy (2021-2030)
  • Table 28 Deep Brain Stimulation Devices in Spain (2021-2030)
  • Table 29 Deep Brain Stimulation Devices in Russia (2021-2030)
  • Table 30 Deep Brain Stimulation Devices in Rest of Europe (2021-2030)
  • Table 31 Deep Brain Stimulation Devices in APAC (2021-2030)
  • Table 32 Deep Brain Stimulation Devices in APAC by Product Type (2021-2030)
  • Table 33 Deep Brain Stimulation Devices in APAC by Battery Type (2021-2030)
  • Table 34 Deep Brain Stimulation Devices in APAC by Application (2021-2030)
  • Table 35 Deep Brain Stimulation Devices in APAC by End User (2021-2030)
  • Table 36 Deep Brain Stimulation Devices in APAC by Country (2021-2030)
  • Table 37 Deep Brain Stimulation Devices in China (2021-2030)
  • Table 38 Deep Brain Stimulation Devices in Japan (2021-2030)
  • Table 39 Deep Brain Stimulation Devices in India (2021-2030)
  • Table 40 Deep Brain Stimulation Devices in Australia (2021-2030)
  • Table 41 Deep Brain Stimulation Devices in South Korea (2021-2030)
  • Table 42 Deep Brain Stimulation Devices in Rest of APAC (2021-2030)
  • Table 43 Deep Brain Stimulation Devices in Rest of World (2021-2030)
  • Table 44 Deep Brain Stimulation Devices in RoW by Product Type (2021-2030)
  • Table 45 Deep Brain Stimulation Devices in RoW by Battery Type (2021-2030)
  • Table 46 Deep Brain Stimulation Devices in RoW by Application (2021-2030)
  • Table 47 Deep Brain Stimulation Devices in RoW by End User (2021-2030)
  • Table 48 Deep Brain Stimulation Devices in RoW by Region (2021-2030)
  • Table 49 Deep Brain Stimulation Devices in Middle East (2021-2030)
  • Table 50 Deep Brain Stimulation Devices in Africa (2021-2030)
  • Table 51 Deep Brain Stimulation Devices in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis
  • Figure 3 Deep Brain Stimulation Devices in Global (2021-2030)
  • Figure 4 Deep Brain Stimulation Devices in Global by Product Type (2021-2030)
  • Figure 5 Deep Brain Stimulation Devices in Global by Battery Type (2021-2030)
  • Figure 6 Deep Brain Stimulation Devices in Global by Application (2021-2030)
  • Figure 7 Deep Brain Stimulation Devices in Global by End User (2021-2030)
  • Figure 8 Deep Brain Stimulation Devices in Global by Geography (2021-2030)
  • Figure 9 Deep Brain Stimulation Devices in North America (2021-2030)
  • Figure 10 Deep Brain Stimulation Devices in North America by Product Type (2021-2030)
  • Figure 11 Deep Brain Stimulation Devices in North America by Battery Type (2021-2030)
  • Figure 12 Deep Brain Stimulation Devices in North America by Application (2021-2030)
  • Figure 13 Deep Brain Stimulation Devices in North America by End User (2021-2030)
  • Figure 14 Deep Brain Stimulation Devices in North America by Country (2021-2030)
  • Figure 15 Deep Brain Stimulation Devices in the US (2021-2030)
  • Figure 16 Deep Brain Stimulation Devices in Canada (2021-2030)
  • Figure 17 Deep Brain Stimulation Devices in Mexico (2021-2030)
  • Figure 18 Deep Brain Stimulation Devices in Europe (2021-2030)
  • Figure 19 Deep Brain Stimulation Devices in Europe by Product Type (2021-2030)
  • Figure 20 Deep Brain Stimulation Devices in Europe by Battery Type (2021-2030)
  • Figure 21 Deep Brain Stimulation Devices in Europe by Application (2021-2030)
  • Figure 22 Deep Brain Stimulation Devices in Europe by End User (2021-2030)
  • Figure 23 Deep Brain Stimulation Devices in Europe by Country (2021-2030)
  • Figure 24 Deep Brain Stimulation Devices in France (2021-2030)
  • Figure 25 Deep Brain Stimulation Devices in Germany (2021-2030)
  • Figure 26 Deep Brain Stimulation Devices in the United Kingdom (2021-2030)
  • Figure 27 Deep Brain Stimulation Devices in Italy (2021-2030)
  • Figure 28 Deep Brain Stimulation Devices in Spain (2021-2030)
  • Figure 29 Deep Brain Stimulation Devices in Russia (2021-2030)
  • Figure 30 Deep Brain Stimulation Devices in Rest of Europe (2021-2030)
  • Figure 31 Deep Brain Stimulation Devices in APAC (2021-2030)
  • Figure 32 Deep Brain Stimulation Devices in APAC by Product Type (2021-2030)
  • Figure 33 Deep Brain Stimulation Devices in APAC by Battery Type (2021-2030)
  • Figure 34 Deep Brain Stimulation Devices in APAC by Application (2021-2030)
  • Figure 35 Deep Brain Stimulation Devices in APAC by End User (2021-2030)
  • Figure 36 Deep Brain Stimulation Devices in APAC by Country (2021-2030)
  • Figure 37 Deep Brain Stimulation Devices in China (2021-2030)
  • Figure 38 Deep Brain Stimulation Devices in Japan (2021-2030)
  • Figure 39 Deep Brain Stimulation Devices in India (2021-2030)
  • Figure 40 Deep Brain Stimulation Devices in Australia (2021-2030)
  • Figure 41 Deep Brain Stimulation Devices in South Korea (2021-2030)
  • Figure 42 Deep Brain Stimulation Devices in Rest of APAC (2021-2030)
  • Figure 43 Deep Brain Stimulation Devices in Rest of World (2021-2030)
  • Figure 44 Deep Brain Stimulation Devices in RoW by Product Type (2021-2030)
  • Figure 45 Deep Brain Stimulation Devices in RoW by Battery Type (2021-2030)
  • Figure 46 Deep Brain Stimulation Devices in RoW by Application (2021-2030)
  • Figure 47 Deep Brain Stimulation Devices in RoW by End User (2021-2030)
  • Figure 48 Deep Brain Stimulation Devices in RoW by Region (2021-2030)
  • Figure 49 Deep Brain Stimulation Devices in Middle East (2021-2030)
  • Figure 50 Deep Brain Stimulation Devices in Africa (2021-2030)
  • Figure 51 Deep Brain Stimulation Devices in South America (2021-2030)
  • Figure 52 Market Drivers
  • Figure 53 Market Barriers
  • Figure 54 Marker Opportunities
  • Figure 55 PORTER'S Five Force Analysis